592 related articles for article (PubMed ID: 25824305)
1. The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.
Notaras M; Hill R; van den Buuse M
Mol Psychiatry; 2015 Aug; 20(8):916-30. PubMed ID: 25824305
[TBL] [Abstract][Full Text] [Related]
2. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
[TBL] [Abstract][Full Text] [Related]
3. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
Notaras M; Hill R; van den Buuse M
Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
[TBL] [Abstract][Full Text] [Related]
4. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
5. No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Ikenouchi-Sugita A; Yoshimura R; Kishi T; Umene-Nakano W; Hori H; Katsuki A; Saito K; Iwata N; Tanaka Y; Nakamura J
Hum Psychopharmacol; 2011; 26(4-5):348-51. PubMed ID: 21678493
[TBL] [Abstract][Full Text] [Related]
6. Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study.
Kirli U; Binbay T; Drukker M; Elbi H; Kayahan B; Gökçelli DK; Özkınay F; Onay H; Alptekin K; van Os J
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):113-121. PubMed ID: 29785763
[TBL] [Abstract][Full Text] [Related]
7. Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.
Ieraci A; Madaio AI; Mallei A; Lee FS; Popoli M
Neuropsychopharmacology; 2016 Dec; 41(13):3070-3079. PubMed ID: 27388329
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
9. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
10. Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Associated with Obsessive-Compulsive Disorder? A Meta-Analysis.
Wang S; Xu X; Yan P; Song M; Li J; Wang S
Psychiatr Danub; 2019 Jun; 31(2):141-147. PubMed ID: 31291217
[TBL] [Abstract][Full Text] [Related]
11. Does BDNF Val66Met Polymorphism Confer Risk for Posttraumatic Stress Disorder?
Wang T
Neuropsychobiology; 2015; 71(3):149-53. PubMed ID: 25925851
[TBL] [Abstract][Full Text] [Related]
12. Impact of genetic variant BDNF (Val66Met) on brain structure and function.
Chen ZY; Bath K; McEwen B; Hempstead B; Lee F
Novartis Found Symp; 2008; 289():180-8; discussion 188-95. PubMed ID: 18497103
[TBL] [Abstract][Full Text] [Related]
13. The BDNF-Val66Met polymorphism modulates parental rearing effects on adult psychiatric symptoms: a community twin-based study.
Ibarra P; Alemany S; Fatjó-Vilas M; Córdova-Palomera A; Goldberg X; Arias B; González-Ortega I; González-Pinto A; Nenadic I; Fañanás L
Eur Psychiatry; 2014 Jun; 29(5):293-300. PubMed ID: 24768157
[TBL] [Abstract][Full Text] [Related]
14. BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders.
Shen T; You Y; Joseph C; Mirzaei M; Klistorner A; Graham SL; Gupta V
Aging Dis; 2018 Jun; 9(3):523-536. PubMed ID: 29896439
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.
Gratacòs M; González JR; Mercader JM; de Cid R; Urretavizcaya M; Estivill X
Biol Psychiatry; 2007 Apr; 61(7):911-22. PubMed ID: 17217930
[TBL] [Abstract][Full Text] [Related]
16. BDNF Val66Met polymorphism moderates the link between child maltreatment and reappraisal ability.
Miu AC; Cărnuţă M; Vulturar R; Szekely-Copîndean RD; Bîlc MI; Chiş A; Cioară M; Fernandez KC; Szentágotai-Tătar A; Gross JJ
Genes Brain Behav; 2017 Apr; 16(4):419-426. PubMed ID: 28009101
[TBL] [Abstract][Full Text] [Related]
17. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
[TBL] [Abstract][Full Text] [Related]
18. BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.
Strube W; Nitsche MA; Wobrock T; Bunse T; Rein B; Herrmann M; Schmitt A; Nieratschker V; Witt SH; Rietschel M; Falkai P; Hasan A
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25612896
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between brain-derived neurotrophic factor Val66Met polymorphism and body mass index change over time in healthy adults.
Nikolac Perkovic M; Mustapic M; Pavlovic M; Uzun S; Kozumplik O; Barisic I; Muck-Seler D; Pivac N
Neurosci Lett; 2013 Jun; 545():127-31. PubMed ID: 23643991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
